The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.

May 20, 2020 — ResearchAndMarkets.com has released its latest report, the "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)"

The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.

Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing ageing population and expanding urbanization are expected to drive the global radiation therapy market. The growth of the market would be challenged by severe side effects of the therapy and stringent regulations and barriers to implementation. A few notable trends may include increasing public awareness, rising preference towards non-invasive procedures and advancements in technology.

The global radiation therapy market can be categorized into external beam radiation therapy, internal beam radiation therapy and others (systemic radiotherapy) on the basis of type. Further, the external beam radiation therapy market is segmented on the basis of type and devices.

Depending upon the type, the global external beam radiation therapy market can be categorized into following categories: intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy and proton therapy. Whereas, on the basis of devices, the global external beam radiation therapy market can be segmented into three categories, named as, LINAC (Linear Accelerators), proton beam therapy devices and compact advanced therapy devices.

The fastest-growing regional market is North America due to continuous inclination to the usage of novel technologies, rising disposable income and healthcare expenditure in the region and rising awareness about procedures and sophisticated diagnostic techniques. Europe represents the second largest radiation therapy market and is already well-penetrated at developed market levels.

For more information: www.researchandmarkets.com/


Related Content

News | Radiopharmaceuticals and Tracers

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
News | Radiation Therapy

September 27, 2023 — The American Society for Radiation Oncology (ASTRO) announced the three winning research proposals ...

Time September 27, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Ultrasound Imaging

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected ...

Time September 08, 2023
arrow
Subscribe Now